semaglutide meds Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Compounded Semaglutide Tablets

Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026

Improves Muscle Recovery Studies show that taking L-carnitine L-tartrate as a dietary supplement significantly reduces recovery time after strenuous exercise 2

This peptide interacts with IGF-1 receptors and increases protein production and tissue growth in research models

The consequences of this assumption are outlined in the discussion

For those who prefer no needles , oral GLP-1 options are now FDA-approved

In this study, we showed GLP-1, but not metformin, rescued MG-induced beta cell apoptosis